Link established between a molecular driver of melanoma & novel therapeutic agent

(The Wistar Institute) Wistar scientists have described a correlation between a key melanoma signaling pathway and a novel class of drugs being tested in the clinic as adjuvant therapy for advanced melanoma, providing useful information for a more effective use of this type of treatment.